Herber DL - Search Results

1

Time-dependent reduction in Abeta levels after intracranial LPS administration in APP transgenic mice.

Herber DL, Roth LM, Wilson D, Wilson N, Mason JE, Morgan D, Gordon MN. Herber DL, et al. Exp Neurol. 2004 Nov;190(1):245-53. doi: 10.1016/j.expneurol.2004.07.007. Exp Neurol. 2004. PMID: 15473997

2

Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice.

Dickey CA, Gordon MN, Wilcock DM, Herber DL, Freeman MJ, Morgan D. Dickey CA, et al. Among authors: herber dl. BMC Neurosci. 2005 Feb 2;6:7. doi: 10.1186/1471-2202-6-7. BMC Neurosci. 2005. PMID: 15689237 Free PMC article.

3

Diverse microglial responses after intrahippocampal administration of lipopolysaccharide.

Herber DL, Maloney JL, Roth LM, Freeman MJ, Morgan D, Gordon MN. Herber DL, et al. Glia. 2006 Mar;53(4):382-91. doi: 10.1002/glia.20272. Glia. 2006. PMID: 16288481

4

Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic mice.

Herber DL, Mercer M, Roth LM, Symmonds K, Maloney J, Wilson N, Freeman MJ, Morgan D, Gordon MN. Herber DL, et al. J Neuroimmune Pharmacol. 2007 Jun;2(2):222-31. doi: 10.1007/s11481-007-9069-z. Epub 2007 Mar 27. J Neuroimmune Pharmacol. 2007. PMID: 18040847

5

Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic mice.

Lebson L, Nash K, Kamath S, Herber D, Carty N, Lee DC, Li Q, Szekeres K, Jinwal U, Koren J, Dickey CA, Gottschall PE, Morgan D, Gordon MN. Lebson L, et al. J Neurosci. 2010 Jul 21;30(29):9651-8. doi: 10.1523/JNEUROSCI.0329-10.2010. J Neurosci. 2010. PMID: 20660248 Free PMC article.

6

Biochemical and histochemical evidence of nonspecific binding of alpha7nAChR antibodies to mouse brain tissue.

Herber DL, Severance EG, Cuevas J, Morgan D, Gordon MN. Herber DL, et al. J Histochem Cytochem. 2004 Oct;52(10):1367-76. doi: 10.1177/002215540405201013. J Histochem Cytochem. 2004. PMID: 15385583

7

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer.

Nagaraj S, Gupta K, Pisarev V, Kinarsky L, Sherman S, Kang L, Herber DL, Schneck J, Gabrilovich DI. Nagaraj S, et al. Among authors: herber dl. Nat Med. 2007 Jul;13(7):828-35. doi: 10.1038/nm1609. Epub 2007 Jul 1. Nat Med. 2007. PMID: 17603493 Free PMC article.

8

Lipid accumulation and dendritic cell dysfunction in cancer.

Herber DL, Cao W, Nefedova Y, Novitskiy SV, Nagaraj S, Tyurin VA, Corzo A, Cho HI, Celis E, Lennox B, Knight SC, Padhya T, McCaffrey TV, McCaffrey JC, Antonia S, Fishman M, Ferris RL, Kagan VE, Gabrilovich DI. Herber DL, et al. Nat Med. 2010 Aug;16(8):880-6. doi: 10.1038/nm.2172. Epub 2010 Jul 11. Nat Med. 2010. PMID: 20622859 Free PMC article.

9

Mechanism and therapeutic reversal of immune suppression in cancer.

Herber DL, Nagaraj S, Djeu JY, Gabrilovich DI. Herber DL, et al. Cancer Res. 2007 Jun 1;67(11):5067-9. doi: 10.1158/0008-5472.CAN-07-0897. Cancer Res. 2007. PMID: 17545581 Free PMC article. No abstract available.

10

Molecular Targets in Cancer Therapy - Fourth Biennial Meeting. Mechanism and therapeutic reversal of immune suppression in cancer.

Herber DL. Herber DL. IDrugs. 2007 Apr;10(4):227-9. IDrugs. 2007. PMID: 17390239 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters